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In eukaryotic cells, most short-lived proteins are degraded by the 
ubiquitin system (Hochstrasser, 1996; Hershko and Ciechanover, 
1998; Weissman, 2001). Modifi  cation of cellular proteins with 
Lys48-linked polyubiquitin chains leads to their degradation 
by the 26S proteasome. Ubiquitylation also participates in 
the down-regulation of plasma membrane proteins, including 
many receptors and transporters. In this case, the targeted pro-
teins are modifi  ed by either a single ubiquitin or short Lys63-
linked ubiquitin oligomers (Galan and Haguenauer-Tsapis, 
1997; Hicke and Dunn, 2003). These modifi  cations do not tar-
get substrate molecules to the proteasome. Instead, they pro-
mote endocytosis of the tagged membrane proteins and their 
traffi  cking to the lysosome (equivalent to the yeast vacuole). 
Ubiquitin-modifi  ed proteins fi  rst sort to the limiting membrane 
of the late endosome, which invaginates at multiple sites, lead-
ing to the accumulation of internal vesicles. The membrane 
proteins accumulate in these vesicles, but ubiquitin does not. 
The mature late endosome structure is called a multivesicular 
body (MVB), which then fuses with the lysosome, resulting in 
breakdown of the internal vesicles by lysosomal lipases and 
proteases (Dupre et al., 2001; Hicke and Dunn, 2003).
Ubiquitin is a relatively stable protein in yeast despite its 
covalent linkage to many proteins destined for proteasomal or 
vacuolar degradation (Swaminathan et al., 1999). This is possi-
ble because ubiquitin-protein modifi  cation is transient. Deubiq-
uitylating enzymes (DUBs) release ubiquitin from polyubiquitin 
conjugates by cleaving the isopeptide bond between the ubiqui-
tins in a chain or at the ubiquitin C terminus linked to substrate. 
The yeast DUB family consists of at least 20 members, includ-
ing 16 in the ubiquitin-specifi  c processing protease (UBP) sub-
family (Amerik et al., 2000b; Verma et al., 2002; Amerik and 
Hochstrasser, 2004).
Mechanisms regulating DUB activity in the cell are only 
beginning to be analyzed. Subcellular localization, posttransla-
tional modifi  cation, and interaction with regulatory factors are 
all likely to play important roles in DUB regulation (Nijman 
et al., 2005). For instance, several DUBs associate with the 26S 
proteasome, and this association is required for full activity. 
Rpn11/POH1, a DUB of the MPN
+/JAMM class, is an integral 
subunit of the proteasome 19S regulatory complex (Verma et al., 
2002; Yao and Cohen, 2002). Its deubiquitylating activity 
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nzyme speciﬁ  city in vivo is often controlled by sub-
cellular localization. Yeast Doa4, a deubiquitylating 
enzyme (DUB), removes ubiquitin from membrane 
proteins destined for vacuolar degradation. Doa4 is re-
cruited to the late endosome after ESCRT-III (endosomal 
sorting complex required for transport III) has assembled 
there. We show that an N-terminal segment of Doa4 is suf-
ﬁ  cient for endosome association. This domain bears four 
conserved elements (boxes A–D). Deletion of the most con-
served of these, A or B, prevents Doa4 endosomal local-
ization. These mutants cannot sustain ubiquitin-dependent 
proteolysis even though neither motif is essential for de-
ubiquitylating activity. Ubiquitin-speciﬁ  c processing protease 
5 (Ubp5), the closest paralogue of Doa4, has no functional 
overlap. Ubp5 concentrates at the bud neck; its N-terminal 
domain is critical for this. Importantly, substitution of the 
Ubp5 N-terminal domain with that of Doa4 relocalizes the 
Ubp5 enzyme to endosomes and provides Doa4 function. 
This is the ﬁ  rst demonstration of a physiologically important 
DUB subcellular localization signal and provides a striking 
example of the functional diversiﬁ  cation of DUB paralogues 
by the evolution of alternative spatial signals.
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requires interaction with other subunits of the 19S complex. 
Ubp6 binds to the 19S subunit Rpn1, and this interaction 
strongly stimulates Ubp6 enzymatic activity (Leggett et al., 
2002). Thus, the activities of both Rpn11 and Ubp6 are delim-
ited to their desired site of action, the proteasome. Other DUBs 
may not need to be regulated in this manner because they have 
intrinsically high substrate specifi  city. For instance, isopepti-
dase T (IsoT) and its yeast orthologue Ubp14 regenerate free 
ubiquitin from unanchored polyubiquitin chains, but no activity 
is seen toward polyubiquitin-protein conjugates (Wilkinson 
et al., 1995; Amerik et al., 1997). This specifi  city was traced to 
an IsoT/Ubp14 element called the ZnF-UBP or DAUP domain 
(Amerik et al., 2000a), which is necessary for ubiquitin binding 
and forms a pocket around the free C-terminal tail of the ubiq-
uitin chain (Reyes-Turcu et al., 2006).
Doa4, a 926-residue yeast DUB of the UBP class, contrib-
utes to the release of ubiquitin from ubiquitin-protein conju-
gates destined for degradation (Papa and Hochstrasser, 1993; 
Papa et al., 1999; Amerik et al., 2000a; Amerik and Hochstrasser, 
2004). The enzyme acts primarily at the late endosome mem-
brane, although genetic and biochemical data suggest that it 
may have additional roles linked to the proteasome (Papa et al., 
1999; Swaminathan et al., 1999). The inactivation of Doa4 leads 
to severe phenotypic abnormalities, including the depletion of 
free ubiquitin, accumulation of apparent proteolytic remnants 
attached to short ubiquitin chains, defects in the proteolysis 
of both proteasomal and vacuolar substrates, hypersensitivity
 to amino acid analogues such as canavanine, and a strong 
sporulation defect.
Multiple observations indicate that Doa4 is responsible 
for deubiquitylating membrane proteins at the MVB. First, doa4 
mutations interact genetically with mutations in class E vacuolar 
protein-sorting (VPS) factors, which are essential for matura-
tion of the late endosome into MVBs (Amerik et al., 2000b). 
Inactivation of these factors compromises MVB vesiculation, 
leading to the accumulation of stacked membrane cisternae 
known as the class E compartment (Rieder et al., 1996), and 
causes strong suppression of the phenotypic abnormalities 
associated with doa4 mutations. Second, Doa4 colocalizes with 
components of the large MVB-localized endosomal sorting 
complex required for transport III (ESCRT-III; Babst et al., 
2002). Specifi   cally, in yeast cells lacking the AAA ATPase 
Vps4, Doa4 accumulates in the class E compartment along 
with the ESCRT-III factors Vps24/Did3 and Snf7/Vps32/Did1 
(Amerik et al., 2000b). Third, transmembrane proteins in transit 
to the vacuole from either the cell surface or the Golgi accumu-
late in ubiquitinated forms in doa4 cells (Dupre et al., 2001; 
Katzmann et al., 2001). Finally, Doa4 is able to bind to the class 
E VPS protein Bro1, which associates directly with the Snf7 
subunit of ESCRT-III; Bro1 may help recruit Doa4 to the late 
endosome (Luhtala and Odorizzi, 2004).
Both endocytic and biosynthetic cargoes need to be ubiq-
uitylated in order to be transported effi  ciently to the vacuolar 
interior. However, Doa4 must remove the ubiquitin tag before 
or during cargo protein movement into the internal vesicles of 
the MVB to prevent ubiquitin from getting degraded along with 
the conjugated cargo protein. Therefore, Doa4 enzyme activity 
needs to be tightly controlled. In this study, we demonstrate 
that binding to the late endosome plays an important role in 
regulating Doa4 function. The N-terminal region of Doa4 is 
both necessary and suffi  cient for this binding. We identifi  ed 
four short conserved sequence blocks within this domain. From 
a deletion analysis of two of these motifs (boxes A and B), 
we determined that although these elements have no role in 
Doa4 expression or catalytic activity, they are critical for its 
physiological function. Deletion of either box A or B causes 
a phenotype equivalent to a complete loss of Doa4, and this 
correlates with the inability of the mutant proteins to interact 
with the late endosome. Notably, an N-terminal fragment of 
Ubp5, another yeast DUB, directs Ubp5 to the yeast bud neck, 
but when this segment is replaced with an N-terminal fragment 
of Doa4, the chimera relocalizes to the late endosome, where 
it can partially substitute for Doa4. These data show that the 
N-terminal extensions of Doa4 and Ubp5 determine their 
respective cellular distributions and that this contributes to the 
functional specialization of these paralogues.
Results
An N-terminal segment of Doa4 allows 
interaction with the late endosome
Several normally soluble ESCRT-III factors, including Snf7 
(Vps32/Did1) and Vps24 (Did3), concentrate in the class E 
compartment in yeast mutants with a defective Vps4 ATPase 
(Babst et al., 1998). A Doa4-GFP fusion protein, which is pri-
marily cytosolic in wild-type cells, also concentrates in sev-
eral spots (usually from one to three per cell) adjacent to the 
vacuole (Amerik et al., 2000b). Colocalization of Doa4-GFP 
and Vps24-HA by indirect immunofl  uorescence  in  vps4∆ 
cells suggested that these spots were class E compartments, 
but low cellular levels of Doa4-GFP made the detection of 
foci diffi  cult. To enhance detection sensitivity and to verify 
the colocalization of endogenous Doa4 with ESCRT-III, 
we constructed wild-type and vps4 strains expressing Doa4 
tagged with nine c-myc epitopes. Cells were costained with 
antibodies against endogenous Snf7 and c-myc. Despite the 
low cellular concentration of Doa4, bright foci were detected 
with the anti-myc antibody in vps4∆ cells, and these foci did 
indeed coincide with those of the ESCRT-III subunit Snf7 
adjacent to vacuoles (Fig. 1 A). 
The UBP subfamily of DUBs, to which Doa4 belongs, 
comprises a diverse set of cysteine proteases with two well-
  conserved motifs, the Cys and His boxes, which include all of 
the active site residues (Hu et al., 2002; Amerik and Hochstras-
ser, 2004). Many UBPs have long N-terminal segments (and 
occasionally C-terminal ones) that extend from the core cata-
lytic domain but are of generally unknown function. These 
extensions may have regulatory roles. In a well-studied example, 
the N-terminal domain of the human UBP called herpesvirus-
associated ubiquitin-specifi  c protease ([HAUSP] USP7) binds the 
p53 tumor suppressor, allowing HAUSP to cleave polyubiquitin-
p53 conjugates and, thereby, limit p53 degradation (Li et al., 
2002). Previously, we had shown that the N-terminal noncata-
lytic region of Doa4 ( 560 residues) conferred Doa4 function ENDOSOMAL TARGETING OF DOA4 • AMERIK ET AL. 827
on the catalytic domain of Ubp5, as did a shorter, 310-residue 
N-terminal Doa4 fragment (Papa et al., 1999).
 We hypothesized that the N-terminal noncatalytic domain 
of Doa4 might target the enzyme to the late endosome mem-
brane. To test this model, we expressed C-terminally truncated 
versions of Doa4 fused to GFP in wild-type and vps4 mutant 
cells and examined their cellular localization (Fig. 1 B). Anti-
GFP immunoblot analysis showed proteins of the expected 
sizes that were expressed at levels similar to or slightly above 
that of the full-length Doa4-GFP fusion protein (Fig. 1 C). The 
Doa41–208-, Doa41–232-, and Doa41–560-GFP fusion proteins were 
all concentrated at the class E compartment in a vps4∆ strain 
(Fig. 1 B and Fig. S1, available at http://www.jcb.org/cgi/con-
tent/full/jcb.200605134/DC1). In vps4∆ cells transformed with 
the Doa41–190-GFP derivative, Doa4 foci were still observed, but 
they were smaller than those of the aforementioned fusions. In 
contrast, localization of Doa41–128-GFP to the late endosome 
was not observed. The modest differences in mutant protein ex-
pression levels did not correlate with class E localization. Col-
lectively, the deletion analysis demonstrated that the fi  rst 208 
residues of Doa4 are suffi  cient for its endosomal localization, 
whereas residues between 129 and 208 are necessary for the in-
teraction. We named the N-terminal 208-residue segment the 
late endosome localization (LEL) domain or signal.
Conserved sequence motifs 
in the LEL domain
We previously isolated the Kluyveromyces lactis DOA4 ortho-
logue by virtue of its ability to suppress the phenotype of a Sac-
charomyces cerevisiae doa4 mutant (Amerik et al., 2000a). 
Overall, the K. lactis enzyme is 43% identical to its S. cerevi-
siae counterpart. The catalytic domains are the most closely re-
lated (64% identity). Several other potential Doa4 orthologues 
have been identifi  ed recently. These include potential ORFs 
from Saccharomyces bayanus (86% identity), Saccharomyces 
mikatae (88% identity), and Eremothecium gossypii (46% iden-
tity; Fig. 2). Doa4 is also 41% identical to the Ubp5 paralogue, 
but, surprisingly, we could detect no functional overlap between 
these two enzymes even when the latter was expressed from a 
high copy plasmid (Papa et al., 1999).
The LEL domain of Doa4 includes four short motifs that 
are well conserved among the Doa4 orthologues. We named 
these boxes A, B, C, and D (Fig. 2). In contrast, Ubp5 has di-
verged substantially in these regions. For instance, in box A, 
there is a negatively charged Glu at the fourth position, where 
there is a positively charged Lys in all of the Doa4 orthologues 
(and an uncharged Gln in the potential orthologue from E. gos-
sypii); a bulky aliphatic at the sixth position but an Ala in Ubp5; 
an Asp at the seventh position versus Glu in Ubp5; and a Leu at 
the ninth residue, where there is a Trp in Ubp5. The potential 
signifi  cance of box D for endosomal localization is suggested 
by the impaired capacity of Doa41–190-GFP, which lacks box D, 
to concentrate at the class E compartment (Fig. 1 B). To address 
the functional relevance of these motifs more fully, we under-
took a detailed analysis of alleles bearing deletions of the two 
most conserved ones, boxes A and B.
Doa4 lacking box A or B 
is nonfunctional in vivo
Mutant doa4 alleles with precise deletions of box A (residues 
51–63) or B (residues 94–100) were generated in the pDOA4-
GFP plasmid backbone, yielding pDOA4∆A- and pDOA4∆B-
GFP. The plasmids were transformed into a doa4∆ strain, and 
expression of the mutant proteins at or above wild-type levels 
was confi  rmed by anti-GFP immunoblot analysis (Fig. 1 B). The 
doa4∆A and doa4∆B mutants were tested by multiple assays. 
Figure 1.  The N-terminal domain of Doa4 is sufﬁ  cient for 
association with the late endosome. (A) Doa4-myc9 and 
Snf7 accumulate in an aberrant late endosome (the class 
E compartment; arrows in A and B) in a vps4 mutant. 
Cells were costained with antibodies to myc and Snf7. 
(B) Localization by GFP ﬂ  uorescence of truncated Doa4-GFP 
fusion proteins in wild-type and vps4∆ cells. (C) Expression 
of the Doa4-GFP derivatives measured by anti-GFP immuno-
blot analysis.JCB • VOLUME 175 • NUMBER 5 • 2006  828
Although wild-type MHY501 cells can survive exposure 
to the arginine analogue canavanine at concentrations up to 
1.5 μg/ml, a doa4∆ mutant (MHY623) cannot form colonies 
even at canavanine levels as low as 0.4 μg/ml. As expected, the 
wild-type Doa4-GFP fusion protein completely suppressed 
the canavanine sensitivity of the doa4∆ mutant. Neither the 
∆A nor ∆B alleles allowed survival on plates with 0.4 μg/ml 
canavanine (Fig. 3 A). 
Another prominent feature of the doa4∆ mutant is the ac-
cumulation of small ubiquitin-containing species, which appear 
to be proteolytic remnants attached to short ubiquitin chains, and 
strongly reduced levels of free ubiquitin (Papa and Hochstrasser, 
1993; Papa et al., 1999). The ∆A and ∆B alleles also could not 
suppress these aberrations and, in fact, caused a further increase 
in levels of the short-chain species (Fig. 3 B). This dominant-
negative effect might refl  ect an interaction of the Doa4 mutants 
with a protein that binds both Doa4 and another DUB that nor-
mally is able to compensate weakly for Doa4 loss.
To examine the role of boxes A and B in Doa4-dependent 
proteolysis, we used pulse-chase analysis to measure degradation 
rates of three well-characterized ubiquitin system substrates in the 
doa4∆A and doa4∆B strains. We used two model test substrates, 
Ub-P–β-galactosidase and L–β-galactosidase, and the naturally 
short-lived transcription factor Matα2. Degradation of all three 
substrates was severely impaired in both mutants (Fig. 4). 
Deubiquitylation at the endosome 
membrane requires Doa4 boxes A and B
Monoubiquitin addition to transmembrane biosynthetic cargo 
destined for the vacuole lumen serves as a signal for cargo sort-
ing to the invaginating vesicles of MVBs; Doa4 is responsible 
for removing ubiquitin before cargo internalization into MVB 
vesicles (Katzmann et al., 2002). A model substrate for this is 
the vacuolar hydrolase carboxypeptidase S (CPS), which is syn-
thesized as an integral membrane protein. In the vacuole, the 
CPS precursor (pCPS) is cleaved from its transmembrane an-
chor by resident hydrolases to yield the mature lumenal form 
(Spormann et al., 1992). Doa4 removes the ubiquitin tag from 
pCPS at the late endosome (Katzmann et al., 2001). We investi-
gated the contribution of Doa4 boxes A and B to this process. 
Figure 2.  Sequence alignments of the N-terminal domains of 
Doa4 and related proteins. S. cerevisiae Doa4 (Z74365), 
S. bayanus potential ORF 21201, S. mikatae potential ORF 
3452, K. lactis Doa4 (AF303215), E. gossypii potential ORF 
(Q754R5), and S. cerevisiae Ubp5 (P39944). Conserved 
boxes A–D are indicated. Deletion endpoints at Asn128, 
Asn190, and Glu208 in S. cerevisiae Doa4 are marked by 
asterisks, and those at Pro35 and Ala162 of Ubp5 are indi-
cated by diamonds.
Figure 3.  Deletion of box A or B in Doa4 abrogates function. (A) Mutant 
doa4∆ cells transformed with plasmids encoding the indicated proteins 
were grown on 0.4 μg/ml canavanine sulfate or control plates. (B) Anti-
ubiquitin immunoblot analysis of the doa4∆ mutant transformed with the 
pDOA4-GFP plasmid or its ∆A or ∆B derivatives. Ubiquitin-peptide conju-
gates are marked with asterisks.ENDOSOMAL TARGETING OF DOA4 • AMERIK ET AL. 829
Anti-CPS immunoblot analysis was performed in transformants 
of a doa4 pep4 prb1 mutant (Fig. 5 A). Inactivation of the Pep4 
and Prb1 vacuolar proteases blocks virtually all vacuolar prote-
olysis, including the cleavage of pCPS, and allows the detection 
of ubiquitylated proteins that enter the vacuole. Monoubiquity-
lated pCPS (pCPS-Ub) accumulated in cells lacking Doa4 as 
expected (Fig. 5 A, fi  rst lane), and this was suppressed by 
pDOA4-GFP (Fig. 5 A, second lane). In contrast, neither 
pDOA4∆A- nor pDOA4∆B-GFP was able to suppress the ac-
cumulation of pCPS-Ub (Fig. 5 A, third and fourth lanes). 
We conclude that boxes A and B are required for the Doa4-
  mediated deubiquitylation of protein cargo in the MVB.
The failure of the box A/B mutants to deubiquitylate pCPS 
was not caused by a defect in Doa4 catalytic activity. Mutant 
versions of Doa4 were expressed in Escherichia coli along with 
the ubiquitin fusion substrate Ub-M–β-galactosidase (Fig. 5 B). 
Cleavage of ubiquitin from M–β-galactosidase by the mutants 
was indistinguishable from wild-type Doa4 in this assay. 
Therefore, these short N-terminal deletions are unlikely to have 
disrupted overall Doa4 folding or catalytic activity and must 
instead impair some other feature of Doa4 function in the cell.
Boxes A and B are the most conserved elements in the 
LEL domain, which targets Doa4 to the late endosome (Fig. 1 B), 
so we tested whether these elements are necessary for this local-
ization function. Indeed, both Doa4∆A- and Doa4∆B-GFP 
failed to concentrate in the class E compartment in vps4 cells 
(Fig. 5 C). Therefore, boxes A and B are required for Doa4 as-
sociation with the late endosome.
The Doa4 LEL signal redirects Ubp5 
to the late endosome
As noted above, S. cerevisiae has an enzyme, Ubp5, that is much 
more closely related to Doa4 than any other DUB in this species. 
The similarity between Doa4 and Ubp5 extends over most of 
their lengths, including the more divergent N-terminal do-
mains (Papa et al., 1999). However, no functional overlap 
between the two proteins has been detected. Potentially, this 
separation of function could derive, at least in part, from the 
segregation of Doa4 and Ubp5 to different cellular compartments. 
The cellular distribution of Ubp5 has not been reported. Therefore, 
we tagged Ubp5 with GFP and examined its localization by 
intrinsic GFP fl  uorescence. The protein was seen throughout 
the cytoplasm and nucleus, but a fraction concentrated at the 
bud neck and incipient bud sites (Fig. 6, A and B).
Given that Ubp5 and Doa4 are most diverged in their 
N termini and that the LEL signal in Doa4 is in its N-terminal ex-
tension, we asked whether the distinct localization of Ubp5 was 
also caused by determinants in its N-terminal region. Residues 
1–35 of Ubp5 have little obvious similarity to Doa4, whereas 
residues 36–162, which align with the LEL region of Doa4, 
have diverged in the regions corresponding to boxes A– D (Fig. 2). 
Like full-length Ubp5-GFP, a fraction of Ubp5∆2–35-GFP local-
ized to the bud neck in dividing yeast cells, but the Ubp5∆2–162
-GFP derivative no longer concentrated there (Fig. 6 A). 
These results suggest that sequences within the Ubp5 segment 
Figure 4. The  doa4 𝖫A and 𝖫B mutants are defective in proteolysis by the 
ubiquitin–proteasome pathway. (A–C) The substrates Ub-P–β-galactosidase 
(A), L–β-galactosidase (B), and α2 (C) were assayed by pulse-chase analy-
sis in doa4∆ cells transformed with empty vector, pDOA4-GFP, or the ∆A 
or ∆B derivatives. Degradation of endogenous α2 was analyzed, whereas 
Ub-P–β-galactosidase and L–β-galactosidase were expressed from 
plasmid-borne GAL-driven alleles induced with galactose.
Figure 5.  Phenotype of the doa4 𝖫A and 𝖫B mutants. (A) Monoubiq-
uitylated CPS precursor (pCPS) accumulates in the doa4  ∆A and ∆B 
mutants. Anti-CPS immunoblot analysis was performed on yeast doa4∆ 
pep4∆ prb1∆ cells expressing the indicated proteins. The pCPS-containing 
bands appear as doublets because pCPS is modiﬁ   ed with one or 
two N-linked core oligosaccharides during its biogenesis (Spormann 
et al., 1992). (B) Deletion of boxes A and B does not affect the enzymatic 
activity of Doa4. Doa4∆A- and Doa4∆B-GFP mutants were coexpressed 
with a ubiquitin-M–β-galactosidase fusion protein in E. coli. Mammalian 
UBPY and the catalytically inactive Doa4-S571 mutant served as positive 
and negative controls, respectively. Extracts were analyzed by anti–β-
galactosidase immunoblotting. (C) Deletion of boxes A and B prevent the 
relocalization of Doa4 to the class E compartment in vps4 cells. Arrow 
marks a class E compartment.JCB • VOLUME 175 • NUMBER 5 • 2006  830
from residues 36 to 162 are necessary for the bud neck localiza-
tion of Ubp5.
We determined whether the N-terminal domain of Doa4 
could redirect Ubp5 to the late endosome and, if so, whether 
this correlated with any ability to provide Doa4 function. Two 
chimeras were constructed: one with the Doa4 LEL domain 
(residues 1–208) replacing the corresponding region of the 
Ubp5 backbone (Doa41–208-Ubp5163–805-GFP) and the other with 
the full Doa4 extension placed upstream of the Ubp5 catalytic 
domain (Doa41–560-Ubp5444–805-GFP). Both fusions showed pre-
dominantly class E compartment localization in vps4∆ cells 
(Fig. 6 B). Interestingly, the LEL domain of Doa4 fused to 
Ubp5 provided partial Doa4 activity; Doa41–208Ubp5163–805-GFP 
was able to suppress, albeit incompletely, the hypersensitivity 
of the doa4∆ strain to canavanine (Fig. 6 C, sectors 2 and 5). 
Ubp5∆2–162-GFP, which lacks the Doa4 LEL signal, does not 
  localize to the late endosome (unpublished data). Thus, the 
N-terminal domains determine the cellular localization of 
Doa4 and Ubp5, and the LEL signal of Doa4 can confer 
Doa4 function on a distinct DUB.
Loss of Bro1 leads to a doa4-like phenotype
Endosomal localization of Doa4, as determined by trapping of 
the protein in the class E compartment in vps4 mutants, requires 
the ESCRT-III components Snf7 and Vps24 (Amerik et al., 
2000b). In another strain background, Snf7 was also found to be 
necessary for such Doa4 localization but Vps24 was not (Luhtala 
and Odorizzi, 2004). At the same time, the latter study impli-
cated another class E VPS factor, Bro1, in recruiting Doa4 to the 
endosome membrane, and the overexpression of Doa4 rescued 
defects associated with a bro1 mutation. Mutations in Bro1 
cause accumulation of the class E compartment and mislocal-
ization of protein cargo there (Odorizzi et al., 2003). Bro1 itself 
accumulates in the class E compartment in cells defective for 
the Vps4 ATPase.
Given that previous studies had already yielded some ap-
parent differences between VPS factor requirements for Doa4 
localization to the endosomes (Amerik et al., 2000b; Luhtala 
and Odorizzi, 2004), we examined the function of Bro1 in more 
detail. First, we analyzed free ubiquitin and ubiquitin-conjugate 
profi  les in cells deleted for the BRO1 gene. Strikingly, a doa4-
like depletion of free ubiquitin and accumulation of small 
ubiquitin-containing species was observed in the bro1∆ mutant 
(Fig. 7 A). Inactivation of Vps4 effi  ciently suppresses the 
phenotypic abnormalities of doa4∆ cells (Amerik et al., 2000b). 
Similarly, strong suppression of the aberrant ubiquitin profi  le of 
bro1∆ was seen in a bro1∆ vps4∆ double mutant (Fig. 7 A). 
These data are consistent with a close link between Bro1 and 
Doa4 function.
If Bro1 were necessary for recruiting Doa4 to the late en-
dosome, bro1∆ vps4∆ cells should no longer concentrate Doa4-
GFP in the class E compartment, as reported previously (Luhtala 
and Odorizzi, 2004). Unexpectedly, we found that the presence 
or absence of Bro1 did not appear to alter the ability of Doa4-
GFP to localize to the class E compartment in vps4∆ cells 
(Fig. 7 B and Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200605134/DC1). These data suggested that yeast might 
have more than one Doa4 receptor for the endosome, although 
Doa4 function in the MVB pathway appears to require Bro1 
(because the loss of Bro1 mimicked the loss of Doa4 phenotypi-
cally). Conceivably, an alternative Doa4 receptor or cofactor 
with lower affi  nity for Doa4 might partially substitute for Bro1 
when Doa4 levels are elevated, as when Doa4-GFP is expressed 
from a multicopy plasmid (Fig. 7 B). The overexpression of 
Doa4 did appear to suppress, albeit only very weakly, the bro1∆ 
defect observed by antiubiquitin blotting (Fig. 7 C).
The strain background used here differed from that used 
in the earlier Bro1 study (Luhtala and Odorizzi, 2004), which 
might also contribute to the differences in genetic requirements 
for Doa4 localization at the late endosome. We note several 
other differences. In the Luhtala and Odorizzi (2004) wild-type 
strain, CPS localizes exclusively within the vacuolar lumen, but 
in our background, a considerable fraction of CPS is found at 
the vacuolar membrane in wild-type cells (unpublished data). In 
addition, Bro1 did not cofractionate with either soluble or 
membrane-bound forms of Doa4 (see Discussion), and we 
failed to detect a two-hybrid interaction between two proteins 
(unpublished data).
Discussion
Ubiquitin-modifi   ed proteins need to be deubiquitylated in 
a regulated manner to ensure that the signaling function of 
Figure 6.  Substitution of the Ubp5 N-terminal domain with the Doa4 LEL 
(residues 1–208) relocalizes the Ubp5 enzyme from the bud neck to endo-
somes and provides Doa4 function. (A) Cellular distribution of Ubp5-GFP 
and N-terminal deletion mutants. (B) Localization of Doa4-Ubp5-GFP chi-
meras in wild-type and vps4 cells. (A and B) Bud neck and bud sites are 
marked by asterisks, and the class E compartment is indicated by arrows. 
(C) Growth of different Doa4-Ubp5 chimeras on 0.4 μg/ml canavanine; 
growth of all strains on control plates is equal (not depicted). 1, wild-type 
cells; 2–7, doa4∆ cells expressing Doa41–208-Ubp5163–805-GFP (2), Doa41–310-
Ubp5265–805-HA (3), Doa41–560-Ubp5444–805-HA (4), vector (5), Doa4 (6), 
and Doa4-GFP (7).ENDOSOMAL TARGETING OF DOA4 • AMERIK ET AL. 831
ubiquitin is not abrogated prematurely. On the other hand, deu-
biquitylation of target proteins may be required to switch them 
to distinct physiological states, and it is also needed to maintain 
suffi  cient levels of active, free ubiquitin in the cell. For instance, 
ubiquitin attachment to a cell surface receptor is a signal for its 
endocytosis, but if Doa4 were to remove the ubiquitin while the 
protein was still at the plasma membrane, the endocytic signal 
would be short circuited. Doa4 appears to only be recruited to 
ubiquitylated membrane proteins after they have reached the 
late endosome (or it may only be activated once there), where it 
cleaves off the ubiquitin moieties before membrane vesicula-
tion into the MVB. This allows the recovery of ubiquitin and 
might also serve as a signal for other traffi  cking steps.
The present structure-function study of the Doa4 DUB 
has demonstrated that an N-terminal segment of its noncatalytic 
domain is both necessary and suffi  cient for directing Doa4 to 
the late endosome. The LEL signal is also able to redirect a 
functionally distinct yeast DUB, Ubp5, to the late endosomal 
membrane, allowing partial recovery of Doa4 function. The 
Ubp5 N-terminal domain normally localizes Ubp5 to the bud 
neck and incipient bud sites. Thus, the noncatalytic domains of 
these enzymes restrict them to distinct cellular sites, helping to 
defi  ne their functional specifi  city.
Restricting DUB activity to speciﬁ  c 
cellular sites
As outlined in the Introduction, Doa4 functions at the late 
endosome. There, it removes ubiquitin from both endocytosed 
membrane proteins and membrane protein cargoes en route 
from the trans-Golgi network to the vacuole. Certain endocytic 
factors are also monoubiquitinated (Hicke and Dunn, 2003), 
and it is possible that Doa4 contributes to their deubiquitylation 
as well. A key question has been how Doa4 is recruited to the 
late endosome.
In this study, we have shown that the fi  rst 208 residues of 
Doa4 are suffi  cient for localization to the class E compartment 
in vps4 cells, indicating that this region functions as a LEL sig-
nal. Within the LEL domain, four short elements, boxes A–D, 
are conserved among Doa4 orthologues but have diverged in 
the S. cerevisiae paralogue Ubp5. Deletion analysis indicates 
that box D contributes to, and boxes A and B are essential 
for, LEL function. The failure of Doa41–128-GFP to localize to 
the class E compartment also suggests that box C is required. 
Consistent with its divergence from Doa4 in the region corre-
sponding to the LEL domain, Ubp5 does not localize to the 
late endosome. Instead, the N-terminal domain of Ubp5 func-
tions in the localization of Ubp5 to the bud neck and incipient 
bud sites.
Importantly, replacement of the N-terminal domain of 
Ubp5 with the LEL signal of Doa4 redirects the Ubp5 enzyme 
to the late endosome, and this chimera can partially suppress the 
phenotype of a doa4-null mutant. This indicates that the Ubp5 
catalytic domain retains a substantial ability to function at the 
endosome on what are normally Doa4 substrates. The release of 
Ubp5 from bud neck–binding sites is not by itself suffi  cient to 
allow Ubp5 to function in place of Doa4. This inference is de-
rived from the fact that Ubp5∆2–162-GFP, which no longer con-
centrates at the bud neck (Fig. 7 A), does not localize to the late 
endosome and is not able to suppress doa4∆ (not depicted). 
Collectively, these results indicate that proper Doa4 regulation 
requires Doa4 recruitment to the late endosome/MVB via its 
N-terminal LEL domain.
Suppression of doa4 defects by the Doa4LEL-Ubp5 chi-
mera is not complete. Our previous experiments revealed that 
sequence differences between the rhodanese homology domain 
(RHD) of Doa4 (residues 199–322) and Ubp5 (148–277) are 
also important for full Doa4 function (Papa et al., 1999). This is 
confi  rmed in Fig. 6 C (compare sector 2 with 3). The exact func-
tions of the RHD in these two enzymes are not known. Neither 
RHD has the catalytic site for rhodanese enzymatic activity; the 
RHD may function as a ubiquitin-binding domain or in sub-
strate binding more generally.
Figure 7.  Functional link between Bro1 and Doa4. (A) The bro1∆ 
  mutant has doa4∆-like ubiquitin homeostasis defects: the accumulation 
of small ubiquitin-containing species (asterisks) and the depletion of free 
ubiquitin (Ub) in bro1∆ cells (antiubiquitin immunoblot). (B) Bro1 is not 
essential for Doa4 localization to the class E compartment in vps4∆ 
cells. Arrows mark class E compartments. (C) Overexpression of Doa4 
weakly suppresses the accumulation of small ubiquitin-containing   species 
in bro1∆ cells. Asterisks mark presumptive ubiquitin-peptide conjugates. 
The bottom panel shows a section of a Coomassie-stained gel to show 
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The previous study of DUB localization most directly rel-
evant to ours is that of Lin et al. (2000), which described the 
differential localization of two isoforms of a testis-specifi  c UBP 
generated by alternative splicing. One isoform localizes to the 
nucleus in developing spermatids, whereas the other is extranu-
clear. The isoforms differ only in their N-terminal extensions. 
When the two N-terminal domains were fused to GFP and ex-
pressed in transiently transfected COS-7 cells, the fusions con-
tinued to show distinct subcellular localization, although the 
difference was not absolute. The functional signifi  cance of the 
different cellular distributions of the testis UBP isoforms was 
not examined.
There are some reports of specifi  c subcellular sites of 
concentration for individual DUBs, but it was not possible in 
either of these earlier studies to verify the physiological re-
quirement for such localization (Murray et al., 2004; Soboleva 
et al., 2005). Among the yeast DUBs, one enzyme, Ubp16, is 
exclusively membrane associated (Kinner and Kölling, 2003). 
Ubp16 localizes to the outer mitochondrial membrane via an 
alanine-rich stretch of amino acids close to its N terminus. This 
motif might function as a membrane anchor. However, the im-
portance of the mitochondrial localization of Ubp16 is unclear. 
Neither ubiquitin-dependent proteolysis nor mitochondrial 
function was detectably altered by loss of the DUB (Kinner and 
Kölling, 2003).
Ubp5: a regulator of cytokinesis?
Cytokinesis in animal and fungal cells occurs through contrac-
tion of an actomyosin ring and subsequent abscission of a 
narrow intercellular bridge (Wolfe and Gould, 2005). In 
S. cerevisiae, several bud neck–localized proteins, including Hof1, 
are required for effi  cient cell separation. Interestingly, the deg-
radation of Hof1 is required for effi  cient actomyosin ring con-
traction and cell separation (Blondel et al., 2005). The cellular 
concentration of Hof1 peaks in cells with large buds and dra-
matically drops during cytokinesis. The SCF
Grr1 ubiquitin ligase 
colocalizes with Hof1 at the bud neck and mediates Hof1 deg-
radation after activation of the mitotic exit network. We have 
found that Ubp5, like Hof1, concentrates at incipient bud sites 
and at the bud neck, although we do not yet know what cel-
lular factors are required for this localization. Ubp5 may re-
move ubiquitin chains from Hof1, thereby rescuing Hof1 
from premature degradation. Consistent with this idea, two-
  hybrid interactions have been detected between Ubp5 and Hof1 
(Ito et al., 2001).
Binding of the Doa4 LEL domain 
to the late endosome
How might boxes A–D in the Doa4 LEL domain function in 
endosomal targeting? The sequences of the Doa4 and Ubp5 
paralogues are suffi  ciently similar in their N-terminal domains 
to infer that the general fold of these regions is likely to be similar 
as well. Despite this, Ubp5, with its more diverged box A–D se-
quences, does not localize to the late endosome. Therefore, we 
imagine that these conserved motifs in Doa4 are at least partly 
exposed at the protein surface and mediate specifi  c protein–
  protein or protein–membrane interactions that are necessary for 
late endosome binding. All four elements include multiple hy-
drophobic residues with interspersed charged or hydrophilic 
amino acids, which would be consistent with such a function.
Cell extraction in the absence of detergents suggests that 
 40% of Doa4 is membrane bound in wild-type cells (unpub-
lished data). Because Doa4 lacks any obvious transmembrane 
segments, it presumably associates peripherally with the late 
endosome/MVB membrane. Such an association could be me-
diated by a protein receptor, specifi  c lipids, or both. We previ-
ously found that inactivation of the ESCRT-III components 
Snf7 or Vps24 prevents the localization of Doa4 to the class E 
compartment, indicating that Doa4 may interact directly or in-
directly with subunits of this complex (Amerik et al., 2000b).
A genetic screen identifi  ed Doa4 as a high copy suppres-
sor of a specifi  c mutant bro1 strain, and subsequent analysis 
suggested that the Bro1 class E VPS factor can bind to Doa4 
and is necessary for recruitment of the DUB to the late endo-
some (Luhtala and Odorizzi, 2004). Consistent with this model, 
we have shown that ubiquitin profi  les of bro1∆ and doa4∆ mu-
tants are very similar, and earlier genetic analysis had also sug-
gested that Bro1 could function before or together with Doa4 in 
the MVB pathway (Nikko et al., 2003). Surprisingly, we con-
tinue to see Doa4 concentrated in the class E compartment of 
vps4∆ bro1∆ cells, indicating that the Bro1 cofactor must do 
more than simply recruit Doa4 to the endosome. Bro1 binds di-
rectly via its so-called Bro1 domain to the Snf7 subunit of 
ESCRT-III (Kim et al., 2005). Therefore, Bro1 could function 
as a bridge between the ESCRT-III complex and Doa4. To date, 
we have not detected binding between Doa4 and Bro1 or any 
ESCRT-III components by either yeast two-hybrid analysis 
or tandem affi  nity purifi  cation (unpublished data). However, 
Bowers et al. (2004) reported a weak two-hybrid interaction 
  between Doa4 and Snf7, although they also did not detect a 
Bro1–Doa4 interaction.
The binding between Bro1 and Doa4 is evidently quite 
weak (or is dynamic) under most conditions, so additional inter-
actions between Doa4 and ESCRT-III components might also 
help recruit the DUB to the late endosome. Another Bro1-domain 
protein in yeast, Rim20, also binds Snf7 but is not required for 
membrane traffi  cking to the vacuole, instead functioning in the 
activation of a transcription factor (Boysen and Mitchell, 2006). 
Nevertheless, Rim20 might function redundantly with Bro1 in 
Doa4 recruitment to the late endosome, which is a possibility 
we are testing.
Various proteomic affi  nity  purifi   cations by different 
groups have yielded other potential Doa4 interactors, but the 
signifi   cance of these interactions remains to be tested (see 
http://www.yeastgenome.org/). One intriguing potential bind-
ing partner is Avt1. This transmembrane protein is an amino 
acid transporter of the vacuole (Russnak et al., 2001), and it 
might be present in prevacuolar compartment membranes. Avt1 
could conceivably have a second function as a Doa4 receptor in 
the late endosome.
Substrate speciﬁ  city of Doa4
The basis of substrate specifi  city among the DUBs is still only 
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has been traced to a specifi  c substrate interaction motif, such as 
in HAUSP (Li et al., 2002), whereas for others, the enzyme has 
a unique way of interacting with the polyubiquitin chain such 
that the chain can only be bound and disassembled if certain 
conditions are met (e.g., the chain has a free proximal end in the 
case of IsoT; Reyes-Turcu et al., 2006). Doa4 must act on a 
wide range of ubiquitin-conjugated substrates, so it is predicted 
to have broad specifi  city. Our data indicate that a major means 
of regulating Doa4 function is through controlled subcellular 
localization. Nevertheless, additional mechanisms are likely to 
regulate its activity. Activity of purifi  ed Doa4 protein is very 
low (Papa and Hochstrasser, 1993; Papa et al., 1999; and unpub-
lished data). The enzyme might be activated by binding to com-
ponents of the MVB machinery (such as Bro1), which is 
analogous to Ubp6 activation by binding to the 26S proteasome 
(Leggett et al., 2002). Catalytic activity of AMSH, a mamma-
lian DUB of the MPN
+/JAMM subfamily that also functions in 
the endocytic pathway, is stimulated by binding a specifi  c 
MVB-sorting factor (McCullough et al., 2006). Doa4 activity 
might also be increased by lipid binding. Alternatively, Doa4 
could be more active against a specifi  c subclass of ubiquitin-
linked substrates such as membrane proteins or those bearing 
Lys63-ubiquitin chains. Additional studies will be needed to 
distinguish between these possibilities.
Materials and methods
Strains, antibodies, and genetic techniques
Yeast strains used in this study are listed in Table I. The E. coli strains used 
for recombinant DNA work were JM101 and TOP10. Yeast and bacterial 
media were prepared as described previously, and standard yeast and 
bacterial molecular genetic methods were used (Ausubel et al., 2002). 
Monoclonal mouse antibodies against ubiquitin, GFP, and the c-myc epit-
ope were purchased from Covance. Polyclonal rabbit antibody against β-
galactosidase was purchased from MP Biomedicals. Rabbit antibodies 
against CPS and Snf7 were gifts from D. Katzmann (Mayo Clinic, Rochester, 
MN). Antibody against Matα2 was described previously (Hochstrasser 
and Varshavsky, 1990).
Yeast strain and plasmid constructions
DOA4 boxes A and B were individually deleted by a two-step PCR-based 
approach (Amerik et al., 1997). A YCplac33 plasmid carrying a 6,149-
bp KpnI–PstI yeast genomic fragment including the DOA4 gene (pDOA4-8) 
was used as a template (Papa and Hochstrasser, 1993). Ampliﬁ  ed DNA 
fragments were cloned into pGEM-T (Promega). The resultant plasmids 
were digested with AgeI and BglII (restriction sites had been introduced 
into the respective ﬂ  anking PCR primers), and the mutant doa4 DNA frag-
ments were cloned into AgeI–BglII-digested pDOA4-GFP, a 2-μm plasmid 
encoding a functional fusion of Doa4 with enhanced GFP. All constructs 
were veriﬁ  ed by DNA sequencing.
The chromosomal BRO1 gene was inactivated by PCR-based gene 
deletion using the pFA6a-TRP1 plasmid (Longtine et al., 1998) as a PCR 
template to create a DNA fragment that directed replacement of the chro-
mosomal BRO1 ORF with the TRP1 gene by homologous recombination in 
MHY606 diploid yeast cells. Trp
+ transformants were checked for the dele-
tion allele by PCR. The heterozygous diploids were sporulated, and tetrads 
were dissected.
An analogous approach was used for constructing plasmids encod-
ing GFP fusions with different portions of Doa4. pFA6a-GFP(S65T)-
HIS3MX6 was used as a template (Longtine et al., 1998). GFP fusions 
were made after Doa4 residues 128, 190, 208, 232, and 560 by recom-
bining in MHY501 yeast cells PCR-ampliﬁ  ed  GFP-HIS3 DNA fragments 
that had sequence identity upstream of the indicated DOA4 codons and 
downstream of the DOA4 stop codon with a cotransformed YEplac195-
DOA4 (URA3) plasmid. His
+ Ura
+ colonies were screened for recombinant 
plasmids by PCR, and the plasmids were recovered in E. coli and reintro-
duced into various yeast strains for localization studies.
To construct plasmids that expressed full-length Ubp5 or the Doa41–560-
Ubp5444–805 chimera as fusions with GFP, the respective DUB ORFs were 
PCR ampliﬁ  ed from either yeast genomic DNA or a plasmid encoding an 
HA-tagged Doa41–560-Ubp5444–805 chimera, which was described previ-
ously (Papa et al., 1999). PCR products were digested with BamHI and 
HindIII and were ligated into BamHI–HindIII-restricted pUG35 (CEN/
URA3; Euroscarf). The Doa41–208-Ubp5163–805 chimera was made by a PCR 
gap repair method that was developed previously (Papa et al., 1999). The 
pUG35-UBP5 plasmid was gapped by digestion with Aﬂ  II and SphI, the 
desired DOA4 segment was ampliﬁ  ed by PCR, and the two DNA frag-
ments were cotransformed into MHY501 yeast cells. Recombinant plas-
mids were recovered in bacteria and sequenced to verify that they had the 
expected exchange of UBP5 and DOA4 sequences.
Plasmids encoding Ubp5∆2–35- and Ubp5∆2–162-GFP were constructed 
by a variation of the PCR gap repair method. pUG35-UBP5 was gapped 
with BamHI and Aﬂ  II, and the large DNA fragment was isolated. Three oli-
gonucleotides were designed as follows: an upstream 46-nucleotide primer 
was derived from the pUG35 sequence and included the start codon of the 
UBP5 gene. The 5′ sequences of two downstream 65-mer oligonucleotides 
matched the noncoding strand of UBP5 downstream of the codons for 
Pro35 and Ala162, respectively. Upstream and downstream pairs of prim-
ers had a 22-base overlap at their 3′ ends that straddled the deletion end-
points. The primers were annealed and extended with Taq DNA polymerase, 
resulting in an 89-bp double-stranded fragment that was introduced into 
yeast cells along with gapped pUG35-UBP5. Recombinant plasmids from 
Ura
+ colonies were recovered in E. coli, and the deletions were veriﬁ  ed by 
DNA sequencing.
Pulse-chase and immunoblot analyses
Pulse-chase analysis of protein degradation was conducted as described 
previously (Chen et al., 1993). Cells were labeled for 5–10 min with 
[
35S]TransLabel (MP Biochemicals). SDS-PAGE gels were dried and analyzed 
using a Storm Phosphorimager and ImageQuant software (GE Healthcare).
Western immunoblot analyses were performed as described previ-
ously (Amerik et al., 1997). For antiubiquitin immunoblotting, cells were 
grown at 30°C to midlogarithmic phase and lysed in SDS gel loading 
buffer by heating to 100°C for 10 min; cleared supernatants were loaded 
onto 16% tricine polyacrylamide gels, and proteins were transferred to 
Immobilon-P membranes (Millipore). Membranes were boiled for 30 min 
in water before incubation with antiubiquitin antibody. Antibody bind-
ing was detected using ECL reagents (GE Healthcare). For anti-GFP 
and -CPS immunoblot analysis, cell extracts were prepared by lysis with 
0.2 M NaOH and 0.2% mercaptoethanol for 10 min on ice (Volland 
et al., 1994). Trichloroacetic acid was added to a ﬁ  nal concentration of 
5%, and the samples were incubated for an additional 10 min on ice. 
Table I. Yeast strains used in this study
Strain Genotype
MHY501 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1
MHY623 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
 doa4-∆1::LEU2
MHY954 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
 doa4-∆1::leu2::TRP1
MHY1942 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
  DOA4-Myc9-his5
+
MHY1947 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
 vps4-∆1::TRP1 DOA4-Myc9-his5
+
MHY2443 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
 vps4-∆1::TRP1
MHY2476 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
 pep4-∆1::HIS3 prb1-∆1::KAN doa4-∆1::LEU2
MHY2718 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
 bro1-∆1::TRP1
MHY2732 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
 bro1-∆1::TRP1 vps4-∆1::HIS5
SEY6210 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-∆901 
 suc2-∆9
PJ69-4A MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-901 
 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-ADE2 met2:GAL7-lacZJCB • VOLUME 175 • NUMBER 5 • 2006  834
Precipitated proteins were collected by centrifugation, neutralized, 
dissolved in loading buffer, loaded onto 10% SDS-polyacrylamide gels, 
and analyzed by immunoblotting.
Fluorescence microscopy
Cellular distributions of Doa4 and Snf7 were examined in ﬁ  xed yeast cells 
by indirect immunoﬂ   uorescence as described previously (Amerik et al., 
2000b). After overnight incubation with primary antibodies, cells were 
washed and incubated for 1 h with secondary antibodies (Oregon green 
anti–mouse and Texas red anti–rabbit IgG conjugates; Invitrogen). GFP 
and FM 4-64 ﬂ  uorescence in live cells was imaged as described previously 
(Amerik et al., 2000b). Samples were viewed on a ﬂ  uorescence micro-
scope (Axioscope; Carl Zeiss MicroImaging, Inc.) with a plan-Apochromat 
100× NA 1.4 objective lens equipped with a CCD camera (Axiocam; 
Carl Zeiss MicroImaging, Inc.). Images were processed using Openlab 
software (version 3.1.5; Improvision). All experiments were conducted at 
room temperature.
Online supplemental material
Fig. S1 shows the colocalization of Doa4- and Doa41–208-GFP with the vital 
dye FM 4-64 to the class E compartment in vps4∆ cells. Fig. S2 demon-
strates continued class E compartment localization of Doa4-GFP in vps4∆ 
bro1∆ cells costained with FM 4-64. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200605134/DC1.
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